Previous findings have shown that mesenchymal stem cells (MSCs) improve renal injury in anti-Thy1 nephritis by preventing the increase in serum creatinine, proteinuria and glomerular histopathology, and this could be mainly attributed to the reduction in cytokine-induced inflammation [4]. This evidence concerns the gene THY1 and nephritis.